Literature DB >> 21148602

Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.

H Y Lee1, H L Tey, S M Pang, T Thirumoorthy.   

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening dermatological conditions that are characterized by mucositis, epidermal detachment and erosions. The underlying etiology in SJS and TEN is almost invariably secondary to drugs. Rarely, other causes such as systemic lupus erythematosus (SLE), infections and vaccinations have been implicated. This report describes three patients with SLE who presented with manifestations of SJS/TEN without a clear drug causality. All three patients presented with photodistributed macular exanthema, which evolved to target lesions, bullae, erosions or sheet-like detachment. This was associated with oral mucositis and conjunctivitis. The onset of the rash was insidious with a protracted clinical course. Ultraviolet exposure and steroid tapering appear to be precipitating factors. In two of the patients, SJS and TEN were the initial presentation of lupus. Although SJS and TEN are almost invariably due to medications, they may, rarely, be an initial presentation of lupus, particularly when associated with an initial photodistribution, absence of genital involvement and a prolonged clinical course.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148602     DOI: 10.1177/0961203310385162

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

Review 1.  Bullous lesions in a patient with systemic lupus erythematosus.

Authors:  Jennifer S Ranario; Jennifer L Smith
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

Review 2.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

3.  Retrospective Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese Patients.

Authors:  Li Wang; Xue-Ling Mei
Journal:  Chin Med J (Engl)       Date:  2017-05-05       Impact factor: 2.628

4.  A case of toxic epidermal necrosis-like cutaneous eruption as the first manifestation and clue to the diagnosis of systemic lupus erythematosus: A case report.

Authors:  Hanieh Zargham; Stephanie Ghazal; Kevin Watters; Khue Huu Nguyen
Journal:  SAGE Open Med Case Rep       Date:  2020-07-15

5.  Bronchiolitis Obliterans After Cefuroxime-Induced Stevens-Johnson Syndrome.

Authors:  Mohammed Shabrawishi; Sultan A Qanash
Journal:  Am J Case Rep       Date:  2019-02-09

6.  Vesiculobullous diseases in relation to lupus erythematosus.

Authors:  Suthinee Rutnin; Kumutnart Chanprapaph
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-04

Review 7.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

8.  TEN/SJS-like lupus erythematosus presentation complicated by COVID-19.

Authors:  Mohammad Shahidi-Dadras; Farnaz Araghi; Arman Ahmadzadeh; Azadeh Rakhshan; Mohammadreza Tabary; Sahar Dadkhahfar
Journal:  Dermatol Ther       Date:  2020-12-10       Impact factor: 3.858

9.  Recurrent Stevens-Johnson syndrome in a patient with systemic lupus erythematosus: a case report.

Authors:  Noha Ibrahim Ahmed Eltahir; Shaima N Elgenaid; Mohammed Elmujtba Adam Essa; Abdelkareem A Ahmed; Ayman Sati Sati Mohamed; Mustafa Mohammed Ali Hussein; Azza Abubaker; Elnazir Mohamed Elsayed; Sulafa Eisa Mohammed Ibrahim; Osman Mohamed Ibrahim; Elnour Mohammed Elagib
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.